Low Anti-CFL1 Antibody with High Anti-ACTB Antibody is a Poor Prognostic Factor in Esophageal Squamous Cell Carcinoma

Overview

Journal Esophagus

Publisher Springer

Specialties Gastroenterology
Oncology

Date 2022 Jul 3

PMID 35780443

Authors

Masaaki Ito

Takaki Hiwasa

Satoshi Yajima

Takashi Suzuki

Yoko Oshima

Tatsuki Nanami

Makoto Sumazaki

Fumiaki Shiratori

Shu-Yang Li

Yasuo Iwadate

Kazuo Sugimoto

Masahiro Mori

Satoshi Kuwabara

Hirotaka Takizawa

Hideaki Shimada

Affiliations

Soon will be listed here.

Abstract

Background: Cofilin (CFL1, actin-binding protein) and β-actin (ACTB) are key molecules in the polymerization and depolymerization of actin microfilaments. The levels of these antibodies were analyzed, and the clinicopathological significance in patients with esophageal carcinoma were evaluated.

Methods: The levels of anti-CFL1 and anti-ACTB antibodies were analyzed in serum samples of patients with esophageal carcinoma and of healthy donors. Eighty-seven cases underwent radical surgery and the clinicopathological characteristics and prognosis was examined.

Results: Serum anti-CFL1 antibody (s-CFL1-Ab) levels and anti-ACTB antibody (s-ACTB-Ab) levels were significantly higher in patients with esophageal carcinoma than in healthy donors. Following the receiver operating characteristic curve analysis between healthy donors and esophageal carcinoma, the sensitivity and specificity for serum anti-CFL1 antibody (s-CFL1-Ab) were 53.3% and 68.8%. The sensitivity and specificity for serum anti-ACTB antibody (s-ACTB-Ab) were 54.9% and 67.7%, respectively. Univariate and multivariate analysis showed that s-CFL1-Ab and s-ACTB-Ab levels were not associated with sex, age, tumor depth, lymph node metastasis, or anti-p53-antibody levels. s-ACTB-Ab levels but not s-CFL1-Ab levels significantly correlated with squamous cell carcinoma antigen. Neither s-CFL1-Ab nor s-ACTB-Ab levels alone were obviously related to overall survival. However, patients with low s-CFL1-Ab levels and high s-ACTB-Ab levels exhibited significantly more unfavorable prognoses than those with high s-CFL1-Ab and low s-ACTB-Ab levels.

Conclusions: Serum levels of anti-CFL1 and anti-ACTB antibodies were significantly higher in patients with esophageal carcinoma than in healthy donors. A combination of low anti-CFL1 and high anti-ACTB antibodies is a poor prognostic factor in esophageal carcinoma.

Citing Articles

Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases.

Hiwasa T, Yoshida Y, Kubota M, Li S, Zhang B, Matsutani T Med Int (Lond). 2024; 4(5):45.

PMID: 38983794 PMC: 11228693. DOI: 10.3892/mi.2024.169.

Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.

Cheng Y, Li Q, Sun G, Li T, Zou Y, Ye H Sci Rep. 2024; 14(1):9757.

PMID: 38684875 PMC: 11058243. DOI: 10.1038/s41598-024-60544-2.

Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.

Ito M, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M Cancer Sci. 2024; 115(7):2209-2219.

PMID: 38634426 PMC: 11247554. DOI: 10.1111/cas.16185.

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma.

Ito M, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M Med Int (Lond). 2023; 3(2):11.

PMID: 36875818 PMC: 9983066. DOI: 10.3892/mi.2023.71.

References

Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y . Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery. 2003; 133(5):486-94. DOI: 10.1067/msy.2003.139. View

Shuto K, Kono T, Shiratori T, Akutsu Y, Uesato M, Mori M . Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET. Esophagus. 2019; 17(3):239-249. PMC: 7316698. DOI: 10.1007/s10388-019-00704-w. View

Zhu Y, He L, Zhang Z, Huang Q . Expression of serum human epididymal secretory protein E4 at low grade and high grade serous carcinomas. Asian Pac J Trop Med. 2012; 5(12):925-30. DOI: 10.1016/S1995-7645(12)60175-8. View

Bravo-Cordero J, Magalhaes M, Eddy R, Hodgson L, Condeelis J . Functions of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol. 2013; 14(7):405-15. PMC: 3878614. DOI: 10.1038/nrm3609. View

Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R . Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A. 1995; 92(25):11810-3. PMC: 40492. DOI: 10.1073/pnas.92.25.11810. View

Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S . Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 2004; 112(6):1029-35. DOI: 10.1002/ijc.20517. View

Nirei T, Tabei T, Sakai N, Koh H, Yoshida M, Fujikawa A . Real-world data in elderly men from Yokosuka City 15 years after introducing prostate-specific antigen-based population screening. Mol Clin Oncol. 2022; 16(2):38. PMC: 8739438. DOI: 10.3892/mco.2021.2471. View

Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y . Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases. Cancer Sci. 2020; 111(12):4453-4464. PMC: 7734161. DOI: 10.1111/cas.14652. View

Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T . Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Front Oncol. 2021; 11:708039. PMC: 8421770. DOI: 10.3389/fonc.2021.708039. View

10.

Kato H, Sato H, Okuda M, Wu J, Koyama S, Izumi Y . Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021; 23(7-8):489-495. DOI: 10.1080/21678421.2021.2012699. View

11.

Shimada H, Shiratori T, Yasuraoka M, Kagaya A, Kuboshima M, Nomura F . Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer. 2009; 9:232. PMC: 2722670. DOI: 10.1186/1471-2407-9-232. View

12.

Machida T, Kubota M, Kobayashi E, Iwadate Y, Saeki N, Yamaura A . Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J Transl Med. 2015; 13:71. PMC: 4344740. DOI: 10.1186/s12967-015-0393-4. View

13.

Zhong Y, Lin H, Li Q, Liu C, Zhong L . Downregulation of long non‑coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA‑422a. Int J Mol Med. 2021; 47(2):659-667. PMC: 7797425. DOI: 10.3892/ijmm.2020.4826. View

14.

Peuchmaur M, DAmore E, Joshi V, Hata J, Roald B, Dehner L . Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003; 98(10):2274-81. DOI: 10.1002/cncr.11773. View

15.

Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S . PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant. 2013; 49(2):195-200. DOI: 10.1038/bmt.2013.147. View

16.

Broll R, Duchrow M, Oevermann E, Wellm C, Schwandner O, Schimmelpenning H . p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue. Int J Colorectal Dis. 2001; 16(1):22-7. DOI: 10.1007/s003840000263. View

17.

Waxman S, Wurmbach E . De-regulation of common housekeeping genes in hepatocellular carcinoma. BMC Genomics. 2007; 8:243. PMC: 1937003. DOI: 10.1186/1471-2164-8-243. View

18.

Bunnell T, Burbach B, Shimizu Y, Ervasti J . β-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell. 2011; 22(21):4047-58. PMC: 3204067. DOI: 10.1091/mbc.E11-06-0582. View

19.

Ruan W, Lai M . Actin, a reliable marker of internal control?. Clin Chim Acta. 2007; 385(1-2):1-5. DOI: 10.1016/j.cca.2007.07.003. View

20.

Meng X, Zhu S, Zong Y, Wang Y, Li P, Zhang S . Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma. Dis Esophagus. 2010; 24(6):444-9. DOI: 10.1111/j.1442-2050.2010.01159.x. View